Dr Reddy#39;s launches generic cancer drug in India

Dr Reddy#39;s launches generic cancer drug in India Patent on Dasatinib is owned by Bristol-Myers-Squibb. The Indian patent has expired on April 12, 2020.

No comments:

Post a Comment